CION Cancer Clinics
ATM beyond breast cancer: the pancreas and the prostate | CION Cancer Clinics
An inherited ATM fault is usually discussed as a breast cancer gene, but it also raises the chance of pancreatic cancer in men and women, and prostate cancer in men. Both rises are real and moderate. This page explains who is offered pancreatic screening, when men should talk about PSA testing, and how an ATM result can change treatment if either cancer is found. At CION Cancer Clinics, our oncologists explain what a gene result means for you and your family, and plan the checks that follow.
On this page
- Does ATM raise pancreatic and prostate cancer risk?
- What does an ATM result change for the pancreas and prostate?
- What should a carrier do about these two cancers?
- The terms in pancreas and prostate plans, explained
- How do the pancreas and prostate plans compare?
- Four things carriers assume, and what is actually true
- What this page cannot tell you
- Common questions about ATM, the pancreas and the prostate
The short answer
Does ATM raise pancreatic and prostate cancer risk?
Yes. Carriers of a faulty ATM copy have a raised lifetime risk of pancreatic cancer, and male carriers have a raised risk of prostate cancer. Both rises are moderate. Most carriers will never develop either cancer, and the plan for each is lighter than many families expect.
Why the pancreas is handled carefully
Pancreatic cancer is hard to find early, which makes screening tempting. But the tests are not simple, they often find harmless changes, and they can lead to surgery that was never needed. For that reason, screening is offered only to carriers whose family history adds extra weight.
Why the prostate matters for the men in the family
Some studies suggest that prostate cancers in ATM carriers are more likely to be the aggressive kind. That makes an earlier conversation about PSA testing sensible. Men are often left out of family genetics, yet a man's result also decides what his daughters and sons may carry.
This page covers inherited ATM faults found on a blood test. Faults found only in a tumour are a different matter, covered in our targeted therapy pages.Four questions, four answers
What does an ATM result change for the pancreas and prostate?
The result touches screening, treatment and family, in different ways for each organ.
Pancreatic screening
Considered when a close blood relative, such as a parent, brother or sister, has had pancreatic cancer. It uses MRI scans or an endoscopic ultrasound in a specialist programme. Without that history, screening is not usually advised.
Prostate screening
Men carrying ATM are usually advised to discuss PSA blood testing earlier than other men. The start age and the gap between tests are agreed with a urologist or oncologist who knows the family history.
If cancer is found
An ATM result can open treatment options, though the benefit is usually smaller than for BRCA carriers.
What may be discussed
- PARP inhibitors in advanced prostate cancer
- Chemotherapy choices in pancreatic cancer
- Clinical trials for DNA-repair faults
For the family
Every blood relative of a carrier, men and women alike, can choose to be tested for the exact fault. Each child of a carrier has a one in two chance of carrying it.
Not sure whether this applies to you?
Ask an oncologistStep by step
What should a carrier do about these two cancers?
-
Draw out the family history on both sides
Note anyone with pancreatic or prostate cancer, and at what age. These two details shape most of the plan.
-
Decide on pancreatic screening with a specialist
If a close relative had pancreatic cancer, ask for referral to a team that runs a high-risk pancreas programme. If not, the usual advice is to know the warning signs and review if the family history changes.
-
Men start the PSA conversation early
A urologist explains what PSA can and cannot show, and agrees whether and when to begin testing.
-
Cut the risks you can control
Not smoking, keeping a healthy weight and managing diabetes lower pancreatic risk for everyone. They matter more, not less, for a carrier.
-
Review when anything changes
A new diagnosis in the family, new symptoms or new guidelines can each change the plan. Keep your counsellor informed.
Words you will hear
The terms in pancreas and prostate plans, explained
- PSA
- Prostate-specific antigen, a blood test that can hint at prostate problems. A raised result needs checking. It is not a diagnosis.
- Endoscopic ultrasound
- A thin camera passed through the mouth into the stomach, with an ultrasound probe that looks closely at the pancreas.
- MRCP
- A type of MRI scan that shows the pancreas and its ducts clearly, without radiation.
- High-risk pancreas programme
- A specialist clinic that screens people with inherited risk and a strong family history, and knows when to hold back.
- PARP inhibitor
- A targeted tablet that can work in cancers with faulty DNA repair.
- Germline
- Present in every cell from birth, and therefore inheritable. A fault found only in the tumour is called somatic.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
How do the pancreas and prostate plans compare?
Commonly believed
Four things carriers assume, and what is actually true
Screening is usually offered only when a close relative has had pancreatic cancer. Scanning everyone can find harmless cysts and lead to surgery nobody needed.
PSA is a snapshot. For a carrier, the value of testing comes from repeating it at agreed intervals and watching the trend, not from a single result.
Pancreatic risk applies to carriers of both sexes. A woman carrying ATM whose father had pancreatic cancer has the same reason to ask about screening as her brother.
PARP inhibitors can help some people with advanced ATM-related prostate cancer, but the benefit is smaller than in BRCA carriers, and no drug is a promise. Your oncologist will weigh them against other options.
Being straight with you
What this page cannot tell you
It cannot tell you whether you personally should be screened, or from what age. That depends on your family history, your health and your exact variant, and it is decided by a specialist. What your specific variant means is a question for the counsellor who ordered the test.
It cannot promise that screening works
Pancreatic screening is still being studied. Early results suggest it can find some cancers at an earlier stage, but studies so far are small, and none has yet shown that it saves lives across all carriers. The evidence on prostate cancer in ATM carriers is also still growing, and Indian data are scarce.
Who this does not apply to
If your ATM result is a variant of uncertain significance, it is not a positive result and these plans do not apply. If the fault was found only in a tumour and not in your blood, it is probably not inherited, and your relatives may not need testing at all.
If you are not sure what kind of ATM result you have, call the helpline and someone will arrange for it to be read properly.Questions we are asked
Common questions about ATM, the pancreas and the prostate
How much does ATM raise pancreatic cancer risk?
The rise is real but moderate, and published figures vary widely between studies. Pancreatic cancer is uncommon to begin with, so even a raised risk leaves most carriers unaffected. A counsellor can give you a clearer sense of your own risk once your family history is known.
What does pancreatic screening involve?
Usually an MRI scan of the pancreas, an endoscopic ultrasound, or both, repeated at intervals set by the specialist team. Findings are reviewed by doctors who see many such scans, because small cysts are common and most are harmless.
When should a male carrier start PSA tests?
Most guidelines suggest an earlier start than for other men, but the exact age depends on the family history and the guideline your doctor follows. Discuss it with a urologist soon after your result, so a plan is in place well before it matters.
I have prostate cancer and carry ATM. Does it change my treatment?
It can, mainly if the cancer is advanced. Your oncologist may consider a PARP inhibitor, and the result may guide the order of other treatments. The benefit in ATM carriers tends to be smaller than in BRCA carriers, so it is weighed against other options.
Should everyone with pancreatic cancer be tested for ATM?
Many guidelines now recommend offering inherited gene testing to everyone diagnosed with pancreatic cancer, because the result can guide treatment and protect relatives. ATM is on the standard panel. Ask the oncologist treating the cancer whether it has been done.
Can diet or lifestyle lower my risk?
Not smoking is the single biggest step for pancreatic risk. Keeping a healthy weight, limiting alcohol and managing diabetes also help. None of this changes the gene, but it lowers the part of your risk that you can control.
My father had pancreatic cancer. Should I be tested?
If he was tested and carried ATM, you can have a targeted test for his exact fault. If he was never tested, a counsellor will look at the wider family history and may suggest testing you directly. Either way, his diagnosis is worth raising.
Where can I have this discussed in Telugu?
A genetic counsellor can go through your report and family tree in Telugu, and refer you for pancreas or prostate checks if needed. Call the CION helpline and describe your report. Someone will arrange an appointment at the nearest centre.
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- NCCN — Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate
- National Cancer Institute — Genetics of Prostate Cancer (PDQ)
- MedlinePlus Genetics — ATM gene
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Carrying ATM and unsure about pancreas or prostate checks?
A genetic counsellor can look at your family history and tell you whether screening is worth it, and refer you on if it is. One helpline serves every CION centre.